To identify a possible trend towards increasing or decreasing CDI rates in our hematology department, we analyzed CDI rates by splitting our AML cohort into two subgroups, one including AML patients diagnosed between 2007 and 2012 and the other one including AML patients diagnosed between 2013 and 2019.
← all excerpts
Use of carbapenems and glycopeptides increases risk for Clostridioides difficile infections in acute myeloid leukemia patients undergoing intensive induction chemotherapy.
1
—
—